ES2071510T3 - Derivados de pirrolidina y de tiazolidina, su preparacion y los medicamentos que les contienen. - Google Patents

Derivados de pirrolidina y de tiazolidina, su preparacion y los medicamentos que les contienen.

Info

Publication number
ES2071510T3
ES2071510T3 ES92915456T ES92915456T ES2071510T3 ES 2071510 T3 ES2071510 T3 ES 2071510T3 ES 92915456 T ES92915456 T ES 92915456T ES 92915456 T ES92915456 T ES 92915456T ES 2071510 T3 ES2071510 T3 ES 2071510T3
Authority
ES
Spain
Prior art keywords
preparation
pirrolidine
thiazolidine
derivatives
medicines containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92915456T
Other languages
English (en)
Inventor
Marc Capet
Claude Cotrel
Claude Guyon
Michel Joannic
Franco Manfre
Gerard Roussel
Marie-Christine Dubroeucq
Michel Cheve
Gilles Dutruc-Rosset
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of ES2071510T3 publication Critical patent/ES2071510T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

COMPUESTOS DE FORMULA (I), SUS SALES, SU PREPARACION Y LOS MEDICAMENTOS QUE LOS CONTIENEN.
ES92915456T 1991-07-10 1992-07-03 Derivados de pirrolidina y de tiazolidina, su preparacion y los medicamentos que les contienen. Expired - Lifetime ES2071510T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9108675A FR2678938B1 (fr) 1991-07-10 1991-07-10 Derives de pyrrolidine, leur preparation et les medicaments les contenant.

Publications (1)

Publication Number Publication Date
ES2071510T3 true ES2071510T3 (es) 1995-06-16

Family

ID=9414933

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92915456T Expired - Lifetime ES2071510T3 (es) 1991-07-10 1992-07-03 Derivados de pirrolidina y de tiazolidina, su preparacion y los medicamentos que les contienen.

Country Status (23)

Country Link
US (1) US5610144A (es)
EP (2) EP0593639B1 (es)
JP (1) JP3034043B2 (es)
KR (1) KR100234927B1 (es)
AT (1) ATE120732T1 (es)
AU (1) AU662345B2 (es)
BR (1) BR1100717A (es)
CA (1) CA2102697C (es)
CZ (1) CZ283602B6 (es)
DE (1) DE69201956T2 (es)
DK (1) DK0593639T3 (es)
ES (1) ES2071510T3 (es)
FI (1) FI105190B (es)
FR (1) FR2678938B1 (es)
HU (1) HU223470B1 (es)
IE (1) IE66331B1 (es)
NO (1) NO180166C (es)
NZ (1) NZ243514A (es)
PL (5) PL171095B1 (es)
RU (1) RU2118316C1 (es)
SK (1) SK1694A3 (es)
WO (1) WO1993001167A1 (es)
ZA (1) ZA925128B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695641B1 (fr) * 1992-09-11 1994-11-25 Rhone Poulenc Rorer Sa (Amino-3 phényl)-1 éthanesulfonate d'hydroquinine optiquement actif, sa préparation et son utilisation.
FR2700166B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
FR2700165B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
FR2700168B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
FR2700167B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine et thiazolidine, leur préparation et les médicaments les contenant.
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
FR2721314B1 (fr) * 1994-06-20 1996-07-19 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
FR2721608B1 (fr) * 1994-06-22 1996-07-19 Rhone Poulenc Rorer Sa Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
FR2734724B1 (fr) * 1995-06-01 1997-07-04 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'alcoolisme
MY114711A (en) * 1995-06-06 2002-12-31 Pfizer Substituted n-(indole-2-carbonyl)-b-alanmamides and derivatives as antidiabetic agents
US6297269B1 (en) 1995-06-06 2001-10-02 Pfizer Inc. Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
FR2744361B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
TW442449B (en) 1996-07-04 2001-06-23 Hoechst Ag Process for preparing 1,2-dichloroethane by direct chlorination
IT1300055B1 (it) * 1998-04-17 2000-04-05 Boehringer Ingelheim Italia Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici
YU26700A (sh) * 1999-05-24 2002-06-19 Pfizer Products Inc. Postupak za cis-1-(2-(4-(6-metoksi-2-fenil-1,2,3,4- tetrahidronaftalen-1-il)fenoksi)etil)pirolidin
CA2413418A1 (en) * 2000-06-21 2001-12-27 Joseph B. Santella Piperidine amides as modulators of chemokine receptor activity
US6277877B1 (en) * 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
CN100400040C (zh) * 2000-10-30 2008-07-09 詹森药业有限公司 三肽酶抑制剂
US7105556B2 (en) 2001-05-30 2006-09-12 Bristol-Myers Squibb Company Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
NZ538567A (en) * 2002-09-19 2007-04-27 Abbott Lab Pyrrolidine-2-carbonitrile derivatives and their pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
US7262207B2 (en) 2002-09-19 2007-08-28 Abbott Laboratories Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
US7238724B2 (en) 2002-09-19 2007-07-03 Abbott Laboratories Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
US6846836B2 (en) * 2003-04-18 2005-01-25 Bristol-Myers Squibb Company N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase
US7230002B2 (en) 2004-02-03 2007-06-12 Glenmark Pharmaceuticals Ltd. Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
AU2005220705A1 (en) * 2004-02-11 2005-09-22 The Ohio State University Research Foundation Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof
WO2007086584A1 (ja) * 2006-01-30 2007-08-02 Meiji Seika Kaisha, Ltd. 新規ＦａｂＫおよびＦａｂＩ／Ｋ阻害剤
US9260411B2 (en) * 2006-07-20 2016-02-16 Abbvie Inc. Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile
US8247438B2 (en) 2008-02-27 2012-08-21 Neuropill, Inc. Methods for treating schizophrenia
CN101407502B (zh) * 2008-11-21 2010-12-22 南京大学 一类n-(叔丁氧基羰基)噻唑烷酸类化合物及其制法和用途
DE102009004204A1 (de) * 2009-01-09 2010-07-15 Christian-Albrechts-Universität Zu Kiel Verfahren zur verbesserten Bioaktivierung von Arzneistoffen
HUE038064T2 (hu) * 2009-12-18 2018-10-29 Ogeda Sa Pirrolidin karboxilsav származékok, mint G-protein kapcsolat receptor 43 (GPR43) agonistái, gyógyszerészeti készítmény és felhasználási eljárások metabolikus rendellenességek kezelésében
WO2012036962A2 (en) 2010-09-13 2012-03-22 Amylin Pharmaceuticals, Inc. C-terminal amidation of polypeptides
ES2755332T3 (es) 2013-11-27 2020-04-22 Epics Therapeutics Compuestos, composición farmacéutica y métodos para su uso en el tratamiento de la inflamación
WO2016118961A1 (en) 2015-01-24 2016-07-28 Academia Sinica Cancer markers and methods of use thereof
WO2021250174A1 (en) * 2020-06-10 2021-12-16 Epics Therapeutics Synthesis of (2s,5r)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH362072A (de) * 1957-03-19 1962-05-31 Ciba Geigy Verfahren zur Herstellung neuer Acylpiperidine
US4499102A (en) * 1979-12-13 1985-02-12 Santen Pharmaceutical Co., Ltd. Thiazolidine and pyrrolidine compounds and pharmaceutical compositions containing them
EP0059966B1 (en) * 1981-03-09 1986-08-13 Merck & Co. Inc. Substituted thiazolidine carboxylic acid analogs and derivatives as antihypertensives
DE3332633A1 (de) * 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel
CA2022346A1 (en) * 1989-08-04 1991-02-05 Mitsubishi Chemical Corporation 1-phenylalkyl-3-phenylurea derivatives
US5258405A (en) * 1990-03-12 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Urea derivatives and salts thereof in method for inhibiting the ACAT enzyme

Also Published As

Publication number Publication date
PL171333B1 (pl) 1997-04-30
HU223470B1 (hu) 2004-07-28
CA2102697A1 (fr) 1993-01-11
EP0527069A1 (fr) 1993-02-10
IE66331B1 (en) 1995-12-27
PL171095B1 (pl) 1997-03-28
WO1993001167A1 (fr) 1993-01-21
BR1100717A (pt) 2000-03-14
SK1694A3 (en) 1994-12-07
PL171112B1 (pl) 1997-03-28
CZ4994A3 (en) 1994-04-13
FI105190B (fi) 2000-06-30
JPH06509331A (ja) 1994-10-20
IE922244A1 (en) 1993-01-13
NO180166B (no) 1996-11-18
FI940072L (fi) 1994-01-07
AU2327592A (en) 1993-02-11
DK0593639T3 (da) 1995-07-03
FI940072A0 (fi) 1994-01-07
AU662345B2 (en) 1995-08-31
US5610144A (en) 1997-03-11
NZ243514A (en) 1995-03-28
NO934300L (no) 1993-11-26
KR100234927B1 (ko) 2000-02-01
FR2678938B1 (fr) 1993-10-08
CZ283602B6 (cs) 1998-05-13
JP3034043B2 (ja) 2000-04-17
NO180166C (no) 1997-02-26
PL171054B1 (pl) 1997-02-28
CA2102697C (fr) 2003-09-30
NO934300D0 (no) 1993-11-26
RU2118316C1 (ru) 1998-08-27
HUT70403A (en) 1995-10-30
ZA925128B (en) 1993-04-28
ATE120732T1 (de) 1995-04-15
EP0593639B1 (fr) 1995-04-05
DE69201956T2 (de) 1995-11-30
FR2678938A1 (fr) 1993-01-15
PL171094B1 (pl) 1997-03-28
EP0593639A1 (fr) 1994-04-27
DE69201956D1 (de) 1995-05-11
HU9400061D0 (en) 1994-05-30

Similar Documents

Publication Publication Date Title
ES2071510T3 (es) Derivados de pirrolidina y de tiazolidina, su preparacion y los medicamentos que les contienen.
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2063036T3 (es) Compuestos (aralquil-sustituido) heterociclicos.
KR870700619A (ko) 피콜린 유도체 및 그 제조방법 및 그 용도 및 그를 포함한 약제
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
LU90944I2 (fr) Dérivés pipérazinyl-héterocycliques
MX9203177A (es) Derivados de 1-fluorofenilbutil-4-(2-pirimidinil)piperazina y composiciones farmaceuticas que los contienen.
ES2093650T3 (es) Una solucion farmaceutica que comprende derivados de fk506.
ES2060799T3 (es) Compuestos flavonoides sustituidos, sus sales, su preparacion y medicinas que contienen estos materiales.
MX9203126A (es) Derivados de sulfonilurea y composiciones farmaceuticas que los contienen.
IT8022265A0 (it) Derivati di alchil-chetoesopiranosidi.
MX9204342A (es) Indoles.
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
AR240945A1 (es) Nuevos derivados de sulfonimidas de acidos aminoetil-fosfonicos y sus sales, procedimiento para prparalos y composiciones herbicidas que los contienen.
ES2116467T3 (es) Derivados de 5h,10h-imidazo(1,2-a)indeno(1,2-e)pirazina-4-ona, su preparacion y los medicamentos que les contienen.
MX9301404A (es) Derivados de 2-oxoquinolina, procedimiento para su preparacion, preparado farmaceutico que los contiene y procedimiento para la obtencion de tal preparado farmaceutico.
MX9305773A (es) 5-oxo-dibenzo/a,d/ciclohepta-1,4-dienos, procedimiento para su obtencion y medicamentos que los contienen.
ES2008109B3 (es) Procedimiento de preparacion de aminoalcoholes y de composiciones farmaceuticas que los contienen.
ES2052954T3 (es) Derivados de imino-2-polifluoroalcoxi-6-benzotiazol, sus procedimientos de preparacion y los medicamentos que les contienen.
ES2071458T3 (es) Nuevos compuestos amidicos de 1-(alcoxi-bencil)-piperacinas, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
DK162682A (da) Oxindolderivater,deres fremstilling og anvendelse
ES2038684T3 (es) Procedimiento de preparacion de derivados de octahidroindol y de compuestos intermedios de su preparacion.
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
ES511329A0 (es) "procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales".
ES2062794T3 (es) Derivados de (alquiltio-3 propil)-3 benzotiazolina, su preparacion y los medicamentos que les contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 593639

Country of ref document: ES